The Alpha-1 Foundation has received the following correspondence from the EveryLife Foundation regarding the introduction of the STAT Act:
I am excited to share that the Speeding Therapy Access Today (STAT) Act of 2021, H.R. 1730 / S. 670 was officially introduced earlier this week by Senators Amy Klobuchar (D-MN) and Roger Wicker (R-MS) in the Senate and Representatives Gus Bilirakis (R-FL) and G.K. Butterfield (D-NC) in the House of Representatives.
This bipartisan legislation is a result of more than a year of collaborative effort by rare disease community partners and congressional leaders, working to identify opportunities to ensure that all rare disease communities receive access to safe and effective treatments and cures at the earliest moment possible.
The STAT Act establishes a Rare Disease Center of Excellence at the FDA that will improve the development of and access to therapies for the rare disease community by:
- Optimizing interagency coordination of rare disease expertise,
- Advancing science-based regulatory policies,
- Targeting development for ultra-rare diseases, and
- Ensuring the intended patient populations ultimately receive access to approved therapies
To help ensure this vision becomes a reality, the most important step you can take today is to contact your Member of Congress and ask that they cosponsor the Speeding Therapy Access Today (STAT) Act. It only takes a minute using our automated action alert.